SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-20-245306
Filing Date
2020-09-14
Accepted
2020-09-14 17:19:00
Documents
2
Period of Report
2020-09-14

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT d37466dpre14a.htm PRE 14A 386237
2 GRAPHIC g37466g19i90.jpg GRAPHIC 67326
  Complete submission text file 0001193125-20-245306.txt   480277
Mailing Address 28159 AVENUE STANFORD SUITE 220 VALENCIA CA 91355
Business Address 28159 AVENUE STANFORD SUITE 220 VALENCIA CA 91355 661-367-9170
Avita Therapeutics, Inc. (Filer) CIK: 0001762303 (see all company filings)

IRS No.: 202578762 | State of Incorp.: DE | Fiscal Year End: 0630
Type: PRE 14A | Act: 34 | File No.: 001-39059 | Film No.: 201173955
SIC: 3841 Surgical & Medical Instruments & Apparatus